Tags

Type your tag names separated by a space and hit enter

[Portacaval shunt with H-grafts of small diameter in treating cirrhotic patients with portal hypertension].
Zhonghua Wai Ke Za Zhi. 1998 Jun; 36(6):330-2.ZW

Abstract

OBJECTIVE

To evaluate the effectiveness of portacaval shunt with H-grafts of small diameter in the treatment of cirrhotic patients with portal hypertension.

METHOD

48 patients cirrhotic with portal hypertension were randomized into three groups: portacaval shunt with H-grafts of 8 mm diameter with external ring reinforced (20 patients), proximal splenorenal shunt (17), and side-to-side portacaval shunt (11). The preoperative liver function in Child's grade and the history of variceal bleeding were the same in the three groups.

RESULT

The postoperative decrease in portal pressure was comparable in the three groups (0.83 +/- 0.31 kPa, 0.81 +/- 0.50 kPa, and 1.02 +/- 0.45 kPa, P > 0.05). There was no significant difference in postoperative rebleeding rate during the follow-up for 15-28 months, and in hospital mortality between the three groups. However, postoperative encephalopathy developed much less in patients undergoing portacaval shunt with H-grafts than those receiving side-to-side portacaval shunt (5.0% vs. 36.4%, P < 0.05). Postoperative transfemoral portography performed within one month showed shunt patency in 95% of the 20 patients undergoing H-graft shunting. B-mode ultrasonography follow-up of up to 15 months also showed shunt patency in all 19 survivals receiving H-graft shunt.

CONCLUSION

This procedure shows less trauma, lower postoperative encephalopathy rate, while as effective in preventing recurrent variceal bleeding as the traditional portosystemic shunt.

Links

Publisher Full Text

Authors+Show Affiliations

Leng X
Department of Surgery, People's Hospital, Beijing Medical University, Beijing 100044.
Zhu J
No affiliation info available
Du R
No affiliation info available

MeSH

AdultAgedBlood Vessel ProsthesisBlood Vessel Prosthesis ImplantationFollow-Up StudiesHumansHypertension, PortalMiddle AgedPortacaval Shunt, SurgicalSplenorenal Shunt, Surgical

Pub Type(s)

Clinical Trial
English Abstract
Journal Article
Randomized Controlled Trial

Language

chi

PubMed ID

11825402

Citation

Leng, X, et al. "[Portacaval Shunt With H-grafts of Small Diameter in Treating Cirrhotic Patients With Portal Hypertension]." Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery], vol. 36, no. 6, 1998, pp. 330-2.
Leng X, Zhu J, Du R. [Portacaval shunt with H-grafts of small diameter in treating cirrhotic patients with portal hypertension]. Zhonghua Wai Ke Za Zhi. 1998;36(6):330-2.
Leng, X., Zhu, J., & Du, R. (1998). [Portacaval shunt with H-grafts of small diameter in treating cirrhotic patients with portal hypertension]. Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery], 36(6), 330-2.
Leng X, Zhu J, Du R. [Portacaval Shunt With H-grafts of Small Diameter in Treating Cirrhotic Patients With Portal Hypertension]. Zhonghua Wai Ke Za Zhi. 1998;36(6):330-2. PubMed PMID: 11825402.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Portacaval shunt with H-grafts of small diameter in treating cirrhotic patients with portal hypertension]. AU - Leng,X, AU - Zhu,J, AU - Du,R, PY - 2002/2/5/pubmed PY - 2004/12/31/medline PY - 2002/2/5/entrez SP - 330 EP - 2 JF - Zhonghua wai ke za zhi [Chinese journal of surgery] JO - Zhonghua Wai Ke Za Zhi VL - 36 IS - 6 N2 - OBJECTIVE: To evaluate the effectiveness of portacaval shunt with H-grafts of small diameter in the treatment of cirrhotic patients with portal hypertension. METHOD: 48 patients cirrhotic with portal hypertension were randomized into three groups: portacaval shunt with H-grafts of 8 mm diameter with external ring reinforced (20 patients), proximal splenorenal shunt (17), and side-to-side portacaval shunt (11). The preoperative liver function in Child's grade and the history of variceal bleeding were the same in the three groups. RESULT: The postoperative decrease in portal pressure was comparable in the three groups (0.83 +/- 0.31 kPa, 0.81 +/- 0.50 kPa, and 1.02 +/- 0.45 kPa, P > 0.05). There was no significant difference in postoperative rebleeding rate during the follow-up for 15-28 months, and in hospital mortality between the three groups. However, postoperative encephalopathy developed much less in patients undergoing portacaval shunt with H-grafts than those receiving side-to-side portacaval shunt (5.0% vs. 36.4%, P < 0.05). Postoperative transfemoral portography performed within one month showed shunt patency in 95% of the 20 patients undergoing H-graft shunting. B-mode ultrasonography follow-up of up to 15 months also showed shunt patency in all 19 survivals receiving H-graft shunt. CONCLUSION: This procedure shows less trauma, lower postoperative encephalopathy rate, while as effective in preventing recurrent variceal bleeding as the traditional portosystemic shunt. SN - 0529-5815 UR - https://www.unboundmedicine.com/medline/citation/11825402/[Portacaval_shunt_with_H_grafts_of_small_diameter_in_treating_cirrhotic_patients_with_portal_hypertension]_ L2 - http://journal.yiigle.com/LinkIn.do?linkin_type=pubmed&amp;issn=0529-5815&amp;year=1998&amp;vol=36&amp;issue=6&amp;fpage=330 DB - PRIME DP - Unbound Medicine ER -